The protein DIIIC‐2, aggregated with a specific oligodeoxynucleotide and adjuvanted in alum, protects mice and monkeys against DENV‐2
Lázaro Gil(Centro de Ingeniería Genética y Biotecnología), Lisset Hermida(Centro de Ingeniería Genética y Biotecnología), Alienys Izquierdo(Instituto de Medicina Tropical “Pedro Kourí”), Rikoi Hitler(Institute of Primate Research), Edith Suzarte(Centro de Ingeniería Genética y Biotecnología), Thomas Kariuki(National Museums of Kenya), Lucy Ochola(Institute of Primate Research), Ernesto Marcos(Centro de Ingeniería Genética y Biotecnología), Iris Valdés(Centro de Ingeniería Genética y Biotecnología), Peris Ambala(Institute of Primate Research), Gerardo Guillén(Hunan City University), James Ndung’u(Institute of Primate Research), Mayling Álvarez(Instituto de Medicina Tropical “Pedro Kourí”), Prisilla Kimiti(Institute of Primate Research), María Guadalupe Guzmán(Instituto de Medicina Tropical “Pedro Kourí”), Laura Lazo(Centro de Ingeniería Genética y Biotecnología)
Cited by 37
Related Papers
Tools for diagnosis, monitoring and screening of <i>Schistosoma</i> infections utilizing lateral-flow based assays and upconverting phosphor labels
|Parasitology|2014|198
Epidermal growth factor in clinical practice – a review of its biological actions, clinical indications and safety implications
|International Wound Journal|2009|167
A novel cancer vaccine composed of human-recombinant epidermal growth factor linked to a carrier protein: Report of a pilot clinical trial
|Annals of Oncology|1998|155
Glucose Toxic Effects on Granulation Tissue Productive Cells: The Diabetics’ Impaired Healing
|BioMed Research International|2012|153
Wound Chronicity, Impaired Immunity and Infection in Diabetic Patients
|MEDICC Review|2021|139